U.S. flag

An official website of the United States government

NM_000179.3(MSH6):c.24C>G (p.Tyr8Ter) AND Lynch syndrome

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Jun 11, 2018
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000825599.4

Allele description [Variation Report for NM_000179.3(MSH6):c.24C>G (p.Tyr8Ter)]

NM_000179.3(MSH6):c.24C>G (p.Tyr8Ter)

Gene:
MSH6:mutS homolog 6 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2p16.3
Genomic location:
Preferred name:
NM_000179.3(MSH6):c.24C>G (p.Tyr8Ter)
HGVS:
  • NC_000002.12:g.47783257C>G
  • NG_007111.1:g.5111C>G
  • NM_000179.3:c.24C>GMANE SELECT
  • NM_001281492.2:c.24C>G
  • NM_001281493.2:c.-713C>G
  • NP_000170.1:p.Tyr8Ter
  • NP_001268421.1:p.Tyr8Ter
  • LRG_219t1:c.24C>G
  • LRG_219:g.5111C>G
  • NC_000002.11:g.48010396C>G
  • NM_000179.2:c.24C>G
  • p.Tyr8X
Protein change:
Y8*
Links:
dbSNP: rs746306598
NCBI 1000 Genomes Browser:
rs746306598
Molecular consequence:
  • NM_001281493.2:c.-713C>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_000179.3:c.24C>G - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001281492.2:c.24C>G - nonsense - [Sequence Ontology: SO:0001587]
Observations:
1

Condition(s)

Name:
Lynch syndrome
Identifiers:
MONDO: MONDO:0005835; MedGen: C4552100

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV000966942Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
criteria provided, single submitter

(LMM Criteria)		Likely pathogenic
(Jun 11, 2018) 		germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot provided11not providednot providednot providedclinical testing

Citations

PubMed

A systematic approach to assessing the clinical significance of genetic variants.

Duzkale H, Shen J, McLaughlin H, Alfares A, Kelly MA, Pugh TJ, Funke BH, Rehm HL, Lebo MS.

Clin Genet. 2013 Nov;84(5):453-63. doi: 10.1111/cge.12257.

PubMed [citation]
PMID:
24033266
PMCID:
PMC3995020

Details of each submission

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV000966942.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (1)

Description

The p.Tyr8X variant in MSH6 has not been previously reported in individuals with MSH6-associated cancers or in large population studies. This nonsense variant l eads to a premature termination codon at position 8, which is predicted to lead to a truncated or absent protein. Heterozygous loss of function of the MSH6 gene is an established disease mechanism in individuals with Lynch syndrome. In summ ary, although additional studies are required to fully establish its clinical si gnificance, the p.Tyr8X variant is likely pathogenic. ACMG/AMP Criteria applied: PVS1; PM2.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot provided1not provided1not provided

Last Updated: Oct 8, 2024